David P. Schenkein
2017
In 2017, David P. Schenkein earned a total compensation of $6M as President and Chief Executive Officer at Agios Pharmaceuticals, a 71% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $456,300 |
|---|---|
| Option Awards | $4,921,476 |
| Salary | $585,040 |
| Other | $9,548 |
| Total | $5,972,364 |
Schenkein received $4.9M in option awards, accounting for 82% of the total pay in 2017.
Schenkein also received $456.3K in non-equity incentive plan, $585K in salary and $9.5K in other compensation.
Rankings
In 2017, David P. Schenkein's compensation ranked 1,480th out of 14,666 executives tracked by ExecPay. In other words, Schenkein earned more than 89.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,480 out of 14,666 | 90th |
Division Manufacturing | 497 out of 5,768 | 91st |
Major group Chemicals And Allied Products | 133 out of 2,074 | 94th |
Industry group Drugs | 96 out of 1,730 | 95th |
Industry Pharmaceutical Preparations | 75 out of 1,329 | 94th |
Source: SEC filing on April 18, 2018.
Schenkein's colleagues
We found four more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2017.